While TGF-β alterations are significant in a wide variety of cancer models, it has been found in a study by Ding et al. that 52.5% of TNBC patients were found to have elevated TGF-β expression, which was associated with increased rates of metastasis, increased tumor grade and negative disease-free survival [166]. Here, TGFB1 is linked to cancer.